Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hull

Showing results (631-640 of 699) with videos related to

Pageof 70
Sort By:
Circulation|December 28, 2017
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial)Gerald Chi, Megan K Yee, Alpesh N Amin, et al.
The New England Journal of Medicine|October 30, 1986
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosisR D Hull, G E Raskob, J Hirsh, et al.
The American Journal of Medicine|January 9, 2007
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harmsRussell D Hull, Graham F Pineo, Rollin F Brant, et al.
The American Journal of Medicine|December 6, 2006
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancerRussell D Hull, Graham F Pineo, Rollin F Brant, et al.
Annals of Internal Medicine|January 1, 1985
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trialR D Hull, J Hirsh, C J Carter, et al.
American Journal of Industrial Medicine|March 26, 1998
Immunologic findings among lead-exposed workersL E Pinkerton, R E Biagini, E M Ward, et al.
Lancet (London, England)|March 7, 1987
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic strokeA G Turpie, M N Levine, J Hirsh, et al.
JAMA Network Open|January 22, 2024
Mental Health Counseling From Conversational Content With Transformer-Based Machine LearningZac E Imel, Michael J Tanana, Christina S Soma, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|August 16, 2000
Three-dimensional ultrasonographic imaging of the neonatal brain in high-risk neonates: preliminary studyC C Salerno, D H Pretorius, S W Hilton, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|May 20, 2004
Uptake of new treatment strategies for deep vein thrombosis: an international auditDrahomir A Aujesky, Jacques Cornuz, Jean-Luc Bosson, et al.
Pageof 70

Showing results (631-640 of 699) with videos related to

Sort By:
Pageof 70
Circulation|December 28, 2017
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial)Gerald Chi, Megan K Yee, Alpesh N Amin, et al.
The New England Journal of Medicine|October 30, 1986
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosisR D Hull, G E Raskob, J Hirsh, et al.
The American Journal of Medicine|January 9, 2007
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harmsRussell D Hull, Graham F Pineo, Rollin F Brant, et al.
The American Journal of Medicine|December 6, 2006
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancerRussell D Hull, Graham F Pineo, Rollin F Brant, et al.
Annals of Internal Medicine|January 1, 1985
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trialR D Hull, J Hirsh, C J Carter, et al.
American Journal of Industrial Medicine|March 26, 1998
Immunologic findings among lead-exposed workersL E Pinkerton, R E Biagini, E M Ward, et al.
Lancet (London, England)|March 7, 1987
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic strokeA G Turpie, M N Levine, J Hirsh, et al.
JAMA Network Open|January 22, 2024
Mental Health Counseling From Conversational Content With Transformer-Based Machine LearningZac E Imel, Michael J Tanana, Christina S Soma, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|August 16, 2000
Three-dimensional ultrasonographic imaging of the neonatal brain in high-risk neonates: preliminary studyC C Salerno, D H Pretorius, S W Hilton, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|May 20, 2004
Uptake of new treatment strategies for deep vein thrombosis: an international auditDrahomir A Aujesky, Jacques Cornuz, Jean-Luc Bosson, et al.
Pageof 70